2019-04
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Endocr Relat Cancer
Song YS, Yoo SK, Kim HH, Jung G, Oh AR, Cha JY, Kim SJ, Cho SW, Lee KE, Seo JS, Park YJ
https://www.ncbi.nlm.nih.gov/pubmed/30999281/
2019-03
Genomic Characterization of Differentiated Thyroid Carcinoma
EEndocrinol Metab (Seoul)
Song YS, Park YJ
https://www.ncbi.nlm.nih.gov/pubmed/30912334/
2019-03
Diagnostic value of computed tomography combined with ultrasonography in detecting cervical recurrence in patients with thyroid cancer
Head Nec
Hong EK, Kim JH, Lee J, Yoo RE, Kim SC, Kim MJ, Park YJ, Chung EJ, Ryu YJ, Lee E, Kang KM, Yun TJ, Choi SH, Sohn CH
https://www.ncbi.nlm.nih.gov/pubmed/30552732/
2019-02
Association Between Diethylhexyl Phthalate Exposure and Thyroid Function: A Meta-Analysis
Thyroid
Kim MJ, Moon S, Oh BC, Jung D, Choi K, Park YJ
https://www.ncbi.nlm.nih.gov/pubmed/30588877/
2019-02
Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
Cancer Res Treat
Kim KN, Hwang Y, Kim K, Lee KE, Park YJ, Choi JY, Park DJ, Cho B, Kang D, Park SK
https://www.ncbi.nlm.nih.gov/pubmed/30786705/
2019-01
Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth
Clin Cancer Res
Song YS, Kim MJ, Sun HJ, Kim HH, Shin HS, Kim YA, Oh BC, Cho SW, Park YJ.
https://www.ncbi.nlm.nih.gov/pubmed/30314969/
SUNGYESA
